Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DOTAP is a **synthetic cationic lipid**—specifically, 1,2-dioleoyl-3-trimethylammonium propane—used predominantly as a **liposomal transfection agent** for delivering DNA, RNA, and other negatively charged molecules to eukaryotic cells in vitro and in vivo[1][4][5][6][7][9]. DOTAP features a quaternary ammonium headgroup linked to two oleic acid tails via ester bonds, producing a permanent positive charge that interacts with nucleic acids and cell membranes[2][4][7]. DOTAP forms stable cationic liposomes or bicelles, efficiently encapsulating and protecting nucleic acids, enabling their uptake through electrostatic interactions and multiple cellular pathways, including clathrin- and caveolin-mediated endocytosis[9]. (R)-DOTAP and (S)-DOTAP are enantiomers with differing biological activities; (R)-DOTAP may produce stronger immunological responses, especially in cancer vaccine models[2]. Commonly used in gene therapy research, DOTAP is chemically available as different salt forms (chloride, methyl sulfate), and as liposomal formulations for transfection, functioning with high efficiency even in serum and suitable for gene knockdown, mRNA, siRNA, and plasmid delivery[3][6]. DOTAP’s primary use is research; it is not an approved pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on DOTAP.